Zhu Meng-Yang, Wang Wei-Ping, Huang Jingjing, Feng Yang-Zheng, Regunathan Soundar, Bissette Garth
Department of Pharmacology, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37604, USA.
Neurochem Int. 2008 Dec;53(6-8):346-54. doi: 10.1016/j.neuint.2008.09.001. Epub 2008 Sep 11.
Agmatine, an endogenous amine derived from decarboxylation of L-arginine catalyzed by arginine decarboxylase, has been proposed as a neurotransmitter or neuromodulator in the brain. In the present study, we examined whether agmatine has neuroprotective effects against repeated immobilization-induced morphological changes in brain tissues and possible effects of immobilization stress on endogenous agmatine levels and arginine decarboxylase expression in rat brains. Sprague-Dawley rats were subjected to 2h immobilization stress daily for 7 days. This paradigm significantly increased plasma corticosterone levels, and the glutamate efflux in the hippocampus as measured by in vivo microdialysis. Immunohistochemical staining with beta-tubulin III showed that repeated immobilization caused marked morphological alterations in the hippocampus and medial prefrontal cortex that were prevented by simultaneous treatment with agmatine (50mg/kg/day), i.p.). Likewise, endogenous agmatine levels measured by high-performance liquid chromatography in the prefrontal cortex, hippocampus, striatum and hypothalamus were significantly increased by immobilization, as compared to controls. The increased endogenous agmatine levels, ranging from 92 to 265% of controls, were accompanied by a significant increase of arginine decarboxylase protein levels in the same regions. These results demonstrate that the administration of exogenous agmatine protects the hippocampus and medial prefrontal cortex against neuronal insults caused by repeated immobilization. The parallel increase in endogenous brain agmatine and arginine decarboxylase protein levels triggered by repeated immobilization indicates that the endogenous agmatine system may play an important role in adaptation to stress as a potential neuronal self-protection mechanism.
胍丁胺是一种由精氨酸脱羧酶催化L-精氨酸脱羧产生的内源性胺,被认为是大脑中的一种神经递质或神经调节剂。在本研究中,我们检测了胍丁胺是否对反复固定应激诱导的脑组织形态变化具有神经保护作用,以及固定应激对大鼠脑内源性胍丁胺水平和精氨酸脱羧酶表达的可能影响。将Sprague-Dawley大鼠每天进行2小时的固定应激,持续7天。这种实验模式显著提高了血浆皮质酮水平以及通过体内微透析测量的海马体中的谷氨酸外流。用β-微管蛋白III进行免疫组织化学染色显示,反复固定应激导致海马体和内侧前额叶皮质出现明显的形态改变,而同时给予胍丁胺(50mg/kg/天,腹腔注射)可预防这些改变。同样,与对照组相比,通过高效液相色谱法测量的前额叶皮质、海马体、纹状体和下丘脑的内源性胍丁胺水平因固定应激而显著升高。内源性胍丁胺水平增加至对照组的92%至265%,同时这些区域的精氨酸脱羧酶蛋白水平也显著增加。这些结果表明,给予外源性胍丁胺可保护海马体和内侧前额叶皮质免受反复固定应激引起的神经元损伤。反复固定应激引发的脑内源性胍丁胺和精氨酸脱羧酶蛋白水平的平行增加表明,内源性胍丁胺系统可能作为一种潜在的神经元自我保护机制在应激适应中发挥重要作用。